February 26, 2018 10:00 AM ESTUpdated 10:28 AM

Global syndicate backs Prokarium's $10M round; Bavarian Nordic to test cancer vaccine with Imfinzi; AI startup buys drug development facility

→ The UK synthetic biology player Prokarium has raised $10 million from a global syndicate of investors to back its work on oral vaccines …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Glob­al syn­di­cate backs Prokar­i­um's $10M round; Bavar­i­an Nordic to test can­cer vac­cine with Imfinzi; AI start­up buys drug de­vel­op­ment fa­cil­i­ty